Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
NCT：NCT02984566 · ACTIVE_NOT_RECRUITING
廣告
NCT IDNCT02984566
狀態ACTIVE_NOT_RECRUITING
開始日期2020-01-14
SponsorUniversity of Sydney (OTHER)
First posted
Last updated
簡要摘要
Primary and secondary liver cancer patients will receive liver SABR with or without KIM intervention.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。